Wana Brands Launches CBD/THC Pomegranate Blueberry Acai Gummies in Colorado Medical Market
Medical product contains double the CBD, THC of adult-use product.
Wana Brands has expanded its product offerings in the Colorado medical cannabis market by launching Pomegranate Blueberry Acai Sour Gummies with a 5:1 CBD/THC ratio.
This ratio can offer medical cannabis patients the therapeutic entourage effect that is found when combining cannabidiol with tetrahydrocannabinol. Wana plans to expand the product into additional medical cannabis markets through the end of the year while many brands continue to prioritize adult-use expansion.
“The medical cannabis market is continuing to shrink as brands are prioritizing the larger adult-use market, meaning some of the most effective ratios just aren’t being produced for medical patients,” said Wana CEO Nancy Whiteman. “It’s critical to patients that brands provide the most effective products available, which is why we’ve launched one of our most popular products, 5:1 CBD/THC gummies, to Colorado’s medical market and look forward to expanding the product into additional medical cannabis markets in the near future.”
Wana’s medical version of the Pomegranate Blueberry Acai Sour Gummies offer a dosage of 50 mg of CBD and 10mg of THC per piece, totaling 1000mg CBD and 200mg THC in the 20-piece container. The adult-use version features 25mg of CBD and 5mg of THC per piece in a 10-piece container.
Whiteman added, “No two cannabis consumers are exactly the same, so having an array of products with varying ratios of CBD and THC can be vital to finding a product and a potency balance that’s right for you.”